370 related articles for article (PubMed ID: 15626517)
1. Provision of HIV treatment in HIV preventive vaccine trials: a developing country perspective.
Slack C; Stobie M; Milford C; Lindegger G; Wassenaar D; Strode A; Ijsselmuiden C
Soc Sci Med; 2005 Mar; 60(6):1197-208. PubMed ID: 15626517
[TBL] [Abstract][Full Text] [Related]
2. Treatment needs in HIV prevention trials: using beneficence to clarify sponsor-investigator responsibilities.
Stobie M; Slack C
Dev World Bioeth; 2010 Dec; 10(3):150-7. PubMed ID: 20002648
[TBL] [Abstract][Full Text] [Related]
3. Microbicide research in developing countries: have we given the ethical concerns due consideration?
Moodley K
BMC Med Ethics; 2007 Sep; 8():10. PubMed ID: 17877834
[TBL] [Abstract][Full Text] [Related]
4. Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa.
Essack Z; Koen J; Barsdorf N; Slack C; Quayle M; Milford C; Lindegger G; Ranchod C; Mukuka R
Dev World Bioeth; 2010 Apr; 10(1):11-21. PubMed ID: 19459900
[TBL] [Abstract][Full Text] [Related]
5. Compensation for research-related injury in NIH-sponsored HIV/AIDS clinical trials in Africa.
Mamotte N; Wassenaar D; Singh N
J Empir Res Hum Res Ethics; 2013 Feb; 8(1):45-54. PubMed ID: 23485670
[TBL] [Abstract][Full Text] [Related]
6. HIV Vaccine Trial participation in South Africa - an ethical assessment.
Moodley K
J Med Philos; 2002 Apr; 27(2):197-215. PubMed ID: 11961697
[TBL] [Abstract][Full Text] [Related]
7. Benefits to research subjects in international trials: do they reduce exploitation or increase undue inducement?
Ballantyne A
Dev World Bioeth; 2008 Dec; 8(3):178-91. PubMed ID: 19046255
[TBL] [Abstract][Full Text] [Related]
8. HIV vaccine trials: reconsidering the therapeutic misconception and the question of what constitutes trial related injuries.
Schüklenk U; Ashcroft R
Dev World Bioeth; 2007 Dec; 7(3):ii-iv. PubMed ID: 18021115
[No Abstract] [Full Text] [Related]
9. Ethical considerations related to the provision of care and treatment in vaccine trials.
Tarantola D; Macklin R; Reed ZH; Kieny MP; Osmanov S; Stobie M; Hankins C
Vaccine; 2007 Jun; 25(26):4863-74. PubMed ID: 17466418
[TBL] [Abstract][Full Text] [Related]
10. Good enough to use for research, but not good enough to benefit from the results of that research: are the clinical HIV vaccine trials in Africa unjust?
Yearby R
De Paul Law Rev; 2004; 53(3):1127-54. PubMed ID: 16200692
[No Abstract] [Full Text] [Related]
11. Relative versus absolute standards for everyday risk in adolescent HIV prevention trials: expanding the debate.
Snyder J; Miller CL; Gray G
Am J Bioeth; 2011 Jun; 11(6):5-13. PubMed ID: 21678205
[TBL] [Abstract][Full Text] [Related]
12. Ethical issues in the NIMH Collaborative HIV/STD Prevention Trial.
NIMH Collaborative HIV/STD Prevention Trial Group
AIDS; 2007 Apr; 21 Suppl 2():S69-80. PubMed ID: 17413266
[TBL] [Abstract][Full Text] [Related]
13. Response to Open Peer Commentaries on "Relative versus absolute standards for everyday risk in adolescent HIV prevention trials: expanding the debate".
Snyder J; Miller CL; Gray G
Am J Bioeth; 2011 Jun; 11(6):W1-3. PubMed ID: 21678202
[No Abstract] [Full Text] [Related]
14. Ethical issues in HIV vaccine trials in South Africa.
Slack C; Lindegger G; Vardas E; Richter L; Strode A; Wassenaar D
S Afr J Sci; 2000 Jun; 96():291-5. PubMed ID: 11863014
[TBL] [Abstract][Full Text] [Related]
15. Views of the process and content of ethical reviews of HIV vaccine trials among members of US institutional review boards and South African research ethics committees.
Klitzman R
Dev World Bioeth; 2008 Dec; 8(3):207-18. PubMed ID: 19046258
[TBL] [Abstract][Full Text] [Related]
16. Why we don't need a relative risk standard for adolescent HIV vaccine trials in South Africa.
Slack CM
Am J Bioeth; 2011 Jun; 11(6):21-2. PubMed ID: 21678209
[No Abstract] [Full Text] [Related]
17. The obligation to provide antiretroviral treatment in HIV prevention trials.
Lo B; Padian N; Barnes M
AIDS; 2007 Jun; 21(10):1229-31. PubMed ID: 17545698
[TBL] [Abstract][Full Text] [Related]
18. HIV vaccine trials: critical issues in informed consent.
Lindegger G; Richter LM
S Afr J Sci; 2000 Jun; 96():313-7. PubMed ID: 15739286
[TBL] [Abstract][Full Text] [Related]
19. Should post-trial provision of beneficial experimental interventions be mandatory in developing countries?
Zong Z
J Med Ethics; 2008 Mar; 34(3):188-92. PubMed ID: 18316461
[TBL] [Abstract][Full Text] [Related]
20. The South African Medical Research Council's Guidelines on Ethics for Medical Research--implications for HIV-preventive vaccine trials with children.
Slack C; Kruger M
S Afr Med J; 2005 Apr; 95(4):269-71. PubMed ID: 15889852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
